Kháng nguyên ung thư-tinh hoàn KK-LC-1 là một dấu ấn sinh học tiềm năng liên quan đến xâm nhập của tế bào miễn dịch trong ung thư biểu mô phổi tuyến

citation_journal_title=CA Cancer J Clin; citation_title=Cancer statistics, 2021; citation_author=RL Siegel, KD Miller, HE Fuchs, A Jemal; citation_volume=71; citation_issue=1; citation_publication_date=2021; citation_pages=7-33; citation_id=CR1 citation_journal_title=Lancet; citation_title=Lung cancer; citation_author=AA Thai, BJ Solomon, LV Sequist, JF Gainor, RS Heist; citation_volume=398; citation_issue=10299; citation_publication_date=2021; citation_pages=535-554; citation_doi=10.1016/S0140-6736(21)00312-3; citation_id=CR2 citation_journal_title=Nature; citation_title=The biology and management of non-small cell lung cancer; citation_author=RS Herbst, D Morgensztern, C Boshoff; citation_volume=553; citation_issue=7689; citation_publication_date=2018; citation_pages=446-454; citation_doi=10.1038/nature25183; citation_id=CR3 citation_journal_title=Cell Death Dis; citation_title=Cell death-based treatment of lung adenocarcinoma; citation_author=TV Denisenko, IN Budkevich, B Zhivotovsky; citation_volume=9; citation_issue=2; citation_publication_date=2018; citation_pages=117; citation_doi=10.1038/s41419-017-0063-y; citation_id=CR4 citation_journal_title=Lancet; citation_title=Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial; citation_author=TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, V Srimuninnimit, KK Laktionov, I Bondarenko; citation_volume=393; citation_issue=10183; citation_publication_date=2019; citation_pages=1819-1830; citation_doi=10.1016/S0140-6736(18)32409-7; citation_id=CR5 citation_journal_title=Hum Antibodies; citation_title=Cancer-testis antigens: an update on their roles in cancer immunotherapy; citation_author=Z Taherian-Esfahani, S Dashti; citation_volume=27; citation_issue=3; citation_publication_date=2019; citation_pages=171-183; citation_doi=10.3233/HAB-190366; citation_id=CR6 citation_journal_title=Clin Cancer Res; citation_title=Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer; citation_author=M Garg, D Chaurasiya, R Rana, N Jagadish, D Kanojia, N Dudha, N Kamran, S Salhan, A Bhatnagar, S Suri; citation_volume=13; citation_issue=5; citation_publication_date=2007; citation_pages=1421-1428; citation_doi=10.1158/1078-0432.CCR-06-2340; citation_id=CR7 citation_journal_title=Cancer; citation_title=Sperm-associated antigen 9 is a biomarker for early cervical carcinoma; citation_author=M Garg, D Kanojia, S Salhan, S Suri, A Gupta, NK Lohiya, A Suri; citation_volume=115; citation_issue=12; citation_publication_date=2009; citation_pages=2671-2683; citation_doi=10.1002/cncr.24293; citation_id=CR8 citation_journal_title=Annu Rev Pharmacol Toxicol; citation_title=Cause and consequence of cancer/testis antigen activation in cancer; citation_author=AW Whitehurst; citation_volume=54; citation_publication_date=2014; citation_pages=251-272; citation_doi=10.1146/annurev-pharmtox-011112-140326; citation_id=CR9 citation_journal_title=Dis Colon Rectum; citation_title=Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel; citation_author=Z Chen, M Li, Y Yuan, Q Wang, L Yan, J Gu; citation_volume=53; citation_issue=1; citation_publication_date=2010; citation_pages=31-38; citation_doi=10.1007/DCR.0b013e3181bdca3a; citation_id=CR10 citation_journal_title=Hum Antibodies; citation_title=Humoral immune responses against cancer-testis antigens in human malignancies; citation_author=M Astaneh, S Dashti, ZT Esfahani; citation_volume=27; citation_issue=4; citation_publication_date=2019; citation_pages=237-240; citation_doi=10.3233/HAB-190377; citation_id=CR11 citation_journal_title=Cancer Res; citation_title=Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma; citation_author=T Fukuyama, T Hanagiri, M Takenoyama, Y Ichiki, M Mizukami, T So, M Sugaya, T So, K Sugio, K Yasumoto; citation_volume=66; citation_issue=9; citation_publication_date=2006; citation_pages=4922-4928; citation_doi=10.1158/0008-5472.CAN-05-3840; citation_id=CR12 citation_journal_title=BMC Cancer; citation_title=KK-LC-1 may be an effective prognostic biomarker for gastric cancer; citation_author=J Ji, J Chen, A Wang, W Zhang, H Ju, Y Liu, L Li; citation_volume=21; citation_issue=1; citation_publication_date=2021; citation_pages=267; citation_doi=10.1186/s12885-021-07974-7; citation_id=CR13 citation_journal_title=Transl Cancer Res; citation_title=Relationship between Kita-Kyushu lung Cancer antigen-1 expression and prognosis of cases with lung squamous cell carcinoma; citation_author=Y Ichiki, T Fukuyama, H Ohmiya, M Ueno, S Yanagi, Y Kanasaki, H Goto, S Mikami, H Yamazaki, K Nakanishi; citation_volume=10; citation_issue=12; citation_publication_date=2021; citation_pages=5212-5221; citation_doi=10.21037/tcr-21-1581; citation_id=CR14 citation_journal_title=Sci Rep; citation_title=Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer; citation_author=C Chen, D Gao, J Huo, R Qu, Y Guo, X Hu, L Luo; citation_volume=11; citation_issue=1; citation_publication_date=2021; citation_pages=12172; citation_doi=10.1038/s41598-021-91290-4; citation_id=CR15 citation_journal_title=Asian Pac J Cancer Prev; citation_title=Reverse Vaccinology approach in constructing a multi-epitope vaccine against Cancer-testis antigens expressed in non-small cell lung Cancer; citation_author=LRM Herrera; citation_volume=22; citation_issue=5; citation_publication_date=2021; citation_pages=1495-1506; citation_doi=10.31557/APJCP.2021.22.5.1495; citation_id=CR16 Ye Z, Liang Y, Ma Y, Lin B, Cao L, Wang B, et al. Targeted photodynamic therapy of cancer using a novel gallium (III) tris (ethoxycarbonyl) corrole conjugated-mAb directed against cancer/testis antigens 83. Cancer Med. 2018. citation_journal_title=Cancer Res; citation_title=TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells; citation_author=T Li, J Fan, B Wang, N Traugh, Q Chen, JS Liu, B Li, XS Liu; citation_volume=77; citation_issue=21; citation_publication_date=2017; citation_pages=e108-e110; citation_doi=10.1158/0008-5472.CAN-17-0307; citation_id=CR18 citation_journal_title=Breast Cancer Res Treat; citation_title=miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients; citation_author=A Lanczky, A Nagy, G Bottai, G Munkacsy, A Szabo, L Santarpia, B Gyorffy; citation_volume=160; citation_issue=3; citation_publication_date=2016; citation_pages=439-446; citation_doi=10.1007/s10549-016-4013-7; citation_id=CR19 citation_journal_title=Nucleic Acids Res; citation_title=Gene expression omnibus: NCBI gene expression and hybridization array data repository; citation_author=R Edgar, M Domrachev, AE Lash; citation_volume=30; citation_issue=1; citation_publication_date=2002; citation_pages=207-210; citation_doi=10.1093/nar/30.1.207; citation_id=CR20 Le T, Aronow RA, Kirshtein A, Shahriyari L. A review of digital cytometry methods: estimating the relative abundance of cell types in a bulk of cells. Brief Bioinform. 2021;22(4). citation_journal_title=Exp Cell Res; citation_title=Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3beta-signaling pathway and the in lung adenocarcinoma; citation_author=L Chen, Q Wu, X Xu, C Yang, J You, F Chen, Y Zeng; citation_volume=398; citation_issue=2; citation_publication_date=2021; citation_pages=112414; citation_doi=10.1016/j.yexcr.2020.112414; citation_id=CR22 citation_journal_title=Int Rev Immunol; citation_title=Cancer-testis antigens and immunotherapy in the light of cancer complexity; citation_author=F Grizzi, L Mirandola, D Qehajaj, E Cobos, JA Figueroa, M Chiriva-Internati; citation_volume=34; citation_issue=2; citation_publication_date=2015; citation_pages=143-153; citation_doi=10.3109/08830185.2015.1018418; citation_id=CR23 Liu X, Xu Y, Xiong W, Yin B, Huang Y, Chu J, et al. Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy. J Immunother Cancer. 2022;10(3). citation_journal_title=Curr Oncol; citation_title=Cancer testis antigen, NOL4, is an immunogenic antigen specifically expressed in small-cell lung Cancer; citation_author=YR Kim, KU Kim, JH Lee, DW Kim, JH Chung, YD Kim, DH Shin, MK Lee, YI Shin, SY Lee; citation_volume=28; citation_issue=3; citation_publication_date=2021; citation_pages=1927-1937; citation_doi=10.3390/curroncol28030179; citation_id=CR25 citation_journal_title=Mol Cancer Ther; citation_title=SAGE1: a potential target antigen for lung Cancer T-cell immunotherapy; citation_author=Y Zhang, X Yu, Q Liu, H Gong, AA Chen, H Zheng, S Zhong, Y Li; citation_volume=20; citation_issue=11; citation_publication_date=2021; citation_pages=2302-2313; citation_doi=10.1158/1535-7163.MCT-21-0203; citation_id=CR26 citation_journal_title=Front Immunol; citation_title=NY-ESO-1 based immunotherapy of Cancer: current perspectives; citation_author=R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, D Bedognetti, J Decock; citation_volume=9; citation_publication_date=2018; citation_pages=947; citation_doi=10.3389/fimmu.2018.00947; citation_id=CR27 citation_journal_title=Anticancer Res; citation_title=Detection of KK-LC-1 protein, a Cancer/testis antigen, in Patients with Breast Cancer; citation_author=Y Kondo, T Fukuyama, R Yamamura, N Futawatari, Y Ichiki, Y Tanaka, Y Nishi, Y Takahashi, H Yamazaki, N Kobayashi; citation_volume=38; citation_issue=10; citation_publication_date=2018; citation_pages=5923-5928; citation_doi=10.21873/anticanres.12937; citation_id=CR28 citation_journal_title=Cell Prolif; citation_title=Hypomethylation-mediated activation of cancer/testis antigen KK-LC-1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling; citation_author=Z Chen, X Zuo, L Pu, Y Zhang, G Han, L Zhang, Z Wu, W You, J Qin, X Dai; citation_volume=52; citation_issue=3; citation_publication_date=2019; citation_pages=e12581; citation_doi=10.1111/cpr.12581; citation_id=CR29 citation_journal_title=Oncotarget; citation_title=Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas; citation_author=R Hsu, Y Baca, J Xiu, R Wang, JN Bodor, C Kim, H Khan, H Mamdani, M Nagasaka, S Puri; citation_volume=12; citation_issue=25; citation_publication_date=2021; citation_pages=2449-2458; citation_doi=10.18632/oncotarget.28132; citation_id=CR30 citation_journal_title=Onco Targets Ther; citation_title=Cancer/testis antigens (CTAs) expression in resected lung cancer; citation_author=S Jin, S Cao, J Li, Q Meng, C Wang, L Yao, Y Lang, J Cao, J Shen, B Pan; citation_volume=11; citation_publication_date=2018; citation_pages=4491-4499; citation_doi=10.2147/OTT.S159491; citation_id=CR31 citation_journal_title=Oncotarget; citation_title=CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer; citation_author=C Paret, P Simon, K Vormbrock, C Bender, A Kolsch, A Breitkreuz, O Yildiz, T Omokoko, S Hubich-Rau, C Hartmann; citation_volume=6; citation_issue=28; citation_publication_date=2015; citation_pages=25356-25367; citation_doi=10.18632/oncotarget.4516; citation_id=CR32 citation_journal_title=J Immunother Cancer; citation_title=Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu lung Cancer Antigen-1; citation_author=B Marcinkowski, S Stevanovic, SR Helman, SM Norberg, C Serna, B Jin, N Gkitsas, T Kadakia, A Warner, JL Davis; citation_volume=7; citation_issue=1; citation_publication_date=2019; citation_pages=229; citation_doi=10.1186/s40425-019-0678-x; citation_id=CR33 citation_journal_title=Arch Immunol Ther Exp; citation_title=Tumor-associated macrophages and regulatory T cells infiltration and the clinical outcome in colorectal Cancer; citation_author=D Waniczek, Z Lorenc, M Snietura, M Wesecki, A Kopec, M Muc-Wierzgon; citation_volume=65; citation_issue=5; citation_publication_date=2017; citation_pages=445-454; citation_doi=10.1007/s00005-017-0463-9; citation_id=CR34 citation_journal_title=J Cell Physiol; citation_title=CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review; citation_author=B Farhood, M Najafi, K Mortezaee; citation_volume=234; citation_issue=6; citation_publication_date=2019; citation_pages=8509-8521; citation_doi=10.1002/jcp.27782; citation_id=CR35 citation_journal_title=Ann Surg; citation_title=Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric Cancer; citation_author=H Zhang, H Liu, Z Shen, C Lin, X Wang, J Qin, X Qin, J Xu, Y Sun; citation_volume=267; citation_issue=2; citation_publication_date=2018; citation_pages=311-318; citation_doi=10.1097/SLA.0000000000002058; citation_id=CR36 citation_journal_title=Cancer Med; citation_title=Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma; citation_author=K Xie, K Zhang, J Kong, C Wang, Y Gu, C Liang, T Jiang, N Qin, J Liu, X Guo; citation_volume=7; citation_issue=1; citation_publication_date=2018; citation_pages=157-166; citation_doi=10.1002/cam4.1248; citation_id=CR37